Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 3033-3039, August 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, C.-H.
Right arrow Articles by Bennett, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, C.-H.
Right arrow Articles by Bennett, L. L., Jr.

Purification and Some Properties of a Deoxyribonucleoside Kinase from L1210 Cells1

Chi-Hsiung Chang2, R. Wallace Brockman and L. Lee Bennett, Jr.

Kettering-Meyer Laboratory, Southern Research Institute, Birmingham, Alabama 35255

A nucleoside kinase has been purified about 1680-fold from L1210 leukemia cells with deoxyadenosine as the phosphate acceptor and with adenosine triphosphate as phosphate donor. The molecular weight of the enzyme, determined by Sephadex G-200 column chromatography, was found to be about 100,000. Purified enzyme, after the final step of purification and also after disc gel electrophoresis (Rf 0.66), catalyzed the phosphorylation of 2'-deoxyadenosine, 2'-deoxyguanosine, 2'-deoxycytidine, 9-ß-D-arabinofuranosyladenine, 9-ß-D-arabinofuranosyl-2-fluoroadenine, 1-ß-D-arabinofuranosylcytosine, and cytidine.

The enzyme exhibited a broad pH optimum ranging from 7.8 to 8.7. Magnesium ion and nucleoside triphosphates were essential for activity. The addition of Ni2+, Zn2+, or Co2+ to the reaction mixture containing 2 mM MgCl2 produced 90 to 100% inhibition of the enzyme activity. The kinase had broad specificity for phosphate donors; adenosine triphosphate, guanosine triphosphate, uridine triphosphate, inosine triphosphate, deoxyuridine triphosphate, and deoxythymidine triphosphate actively donated phosphate to deoxyadenosine as did several nucleoside triphosphate analogs. The Michaelis constant for deoxyadenosine varied with the phosphate donor; the apparent Km values with adenosine triphosphate and uridine triphosphate as donor were 1.25 and 0.13 mM, respectively. Apparent Km values (0.25 mM) with deoxyuridine triphosphate and deoxythymidine triphosphate also were lower than those obtained with adenosine triphosphate as donor, but guanosine triphosphate and inosine triphosphate gave the same constant as adenosine triphosphate. The apparent Vmax for phosphorylation of deoxyadenosine was severalfold higher with adenosine triphosphate than with uridine triphosphate. The apparent Michaelis constants for deoxyguanosine, deoxycytidine, and cytidine with adenosine triphosphate as phosphate donor were 1.37, 8.0, and 33 mM, respectively. Since deoxyadenosine and deoxyguanosine were the best substrates, this enzyme may be regarded as a purine deoxyribonucleoside kinase.

1 This investigation was supported by USPHS Grant RO1-CA-23155 awarded by the National Cancer Institute and Grant SO7-RR-05676, Division of Research Resources, Department of Health and Human Services.

2 To whom requests for reprints should be addressed.

Received 12/ 3/81. Accepted 5/ 6/82.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.